focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Director/PDMR Shareholding

14 Mar 2012 17:59

RNS Number : 3791Z
e-Therapeutics plc
14 March 2012
 

 

e-Therapeutics plc ("e-Therapeutics" or the "Company")

14 March 2012

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

The Company was informed on 13 March 2012 that, on that day, Oliver James, Non- executive Chairman, purchased 34,500 ordinary shares in the Company at 29.0p per share.

Professor James's resultant total holding is 98,000 ordinary shares representing 0.1% of the issued share capital of the Company which currently stands at 138,126,467 shares all carrying voting rights.

Contacts

e-Therapeutics plc Tel: +44 (0)79 0991 5068

Daniel Elger

Panmure Gordon (UK) Limited Tel: +44 (0)20 7459 3600

Andrew Burnett/ Fred Walsh

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFEDVDISLIF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.